Obese women are 70% more likely to develop pancreatic cancer

20 July 2008

Obese women who carry most of their excess weight around the stomach are 70% more likely to develop pancreatic cancer, according to a study published on-line by the British Journal of Cancer.

A team of researchers followed over 138,000 post-menopausal women in the USA for over seven years to investigate the effects of obesity on pancreatic cancer as a part of the Women's Health Initiative. 251 women in the study developed pancreatic cancer. Of these, 78 were in the group with highest the waist-to-hip ratios. This is 70% more (after adjusting for other potential risk factors including age and smoking status) than the 34 women with the lowest waist-to-hip ratios who went on to develop the disease.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK









Company Spotlight